ChrysCapital has secured a record $2.2 billion for its latest fund, ChrysCapital X. This marks a significant achievement for the Indian private equity firm. The fund saw strong participation from both global and domestic investors. ChrysCapital’s strategy focuses on key sectors like consumer, healthcare, and technology. The firm has a proven track record of delivering substantial returns to its investors.
Astral shares drop 6% after demerger. What should investors do?
Astral shares fell nearly 6% on Monday after the company’s board approved the demerger of its chemicals business into a newly incorporated entity, Astral Chemie.